These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 17827005

  • 1. Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.
    Anandan SK, Ward JS, Brokx RD, Denny T, Bray MR, Patel DV, Xiao XY.
    Bioorg Med Chem Lett; 2007 Nov 01; 17(21):5995-9. PubMed ID: 17827005
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
    Suzuki T, Matsuura A, Kouketsu A, Hisakawa S, Nakagawa H, Miyata N.
    Bioorg Med Chem; 2005 Jul 01; 13(13):4332-42. PubMed ID: 15927839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Lee S, Shinji C, Ogura K, Shimizu M, Maeda S, Sato M, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4895-900. PubMed ID: 17588744
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C, Maeda S, Imai K, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7625-51. PubMed ID: 16877001
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of rigid trichostatin A analogs as HDAC inhibitors.
    Charrier C, Bertrand P, Gesson JP, Roche J.
    Bioorg Med Chem Lett; 2006 Oct 15; 16(20):5339-44. PubMed ID: 16904890
    [Abstract] [Full Text] [Related]

  • 8. Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors.
    Giannini G, Marzi M, Marzo MD, Battistuzzi G, Pezzi R, Brunetti T, Cabri W, Vesci L, Pisano C.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2840-3. PubMed ID: 19359173
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Pabba C, Gregg BT, Kitchen DB, Chen ZJ, Judkins A.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):324-8. PubMed ID: 21109435
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Dallavalle S, Cincinelli R, Nannei R, Merlini L, Morini G, Penco S, Pisano C, Vesci L, Barbarino M, Zuco V, De Cesare M, Zunino F.
    Eur J Med Chem; 2009 May 01; 44(5):1900-12. PubMed ID: 19084294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
    Kim SA, Jin YL, Kim HS.
    Arch Pharm Res; 2009 Jan 01; 32(1):15-21. PubMed ID: 19183872
    [Abstract] [Full Text] [Related]

  • 17. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
    Krennhrubec K, Marshall BL, Hedglin M, Verdin E, Ulrich SM.
    Bioorg Med Chem Lett; 2007 May 15; 17(10):2874-8. PubMed ID: 17346959
    [Abstract] [Full Text] [Related]

  • 18. Exploring alternative Zn-binding groups in the design of HDAC inhibitors: squaric acid, N-hydroxyurea, and oxazoline analogues of SAHA.
    Hanessian S, Vinci V, Auzzas L, Marzi M, Giannini G.
    Bioorg Med Chem Lett; 2006 Sep 15; 16(18):4784-7. PubMed ID: 16870438
    [Abstract] [Full Text] [Related]

  • 19. Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
    Tessier P, Smil DV, Wahhab A, Leit S, Rahil J, Li Z, Déziel R, Besterman JM.
    Bioorg Med Chem Lett; 2009 Oct 01; 19(19):5684-8. PubMed ID: 19699639
    [Abstract] [Full Text] [Related]

  • 20. Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups.
    Butler KV, He R, McLaughlin K, Vistoli G, Langley B, Kozikowski AP.
    ChemMedChem; 2009 Aug 01; 4(8):1292-301. PubMed ID: 19551801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.